Hormone/Behavior Relations of Clinical Importance -

Hormone/Behavior Relations of Clinical Importance (eBook)

Endocrine Systems Interacting with Brain and Behavior
eBook Download: PDF | EPUB
2010 | 1. Auflage
1182 Seiten
Elsevier Science (Verlag)
978-0-08-095800-2 (ISBN)
Systemvoraussetzungen
Systemvoraussetzungen
170,00 inkl. MwSt
  • Download sofort lieferbar
  • Zahlungsarten anzeigen
A single volume of 41 articles, Hormone/Behavior Relations of Clinical Importance is an authoritative selection of relevant chapters from the Hormones Brain and Behavior 2e MRW, the most comprehensive source of neuroendocrinological information assembled to date (AP July 2009).

The study of hormones as they impact the brain and, subsequently, behavior is a central topic in neuroscience, endocrinology and psychiatry. This volume offers an overview of neuroendocrinological topics, approaching the subject from the perspective of hormone-brain function, hormone-behavior relations, sex differences, and the impact on various diseases/pathologies. Many basic human behavioral functions are subject to the influence of hormones - sexual orientation, the experience of pain, fertility, immunity - as are clinical conditions such as diabetes, substance abuse disorder, eating disorders, PTSD, TBI, pain, Alzheimer's, stress/anxiety, affective disorders, and more. There is considerable commercial clinical potential in the study of hormones - drug companies are currently developing a Cholecystokinin (hormonal peptide) booster to reduce appetite in those who suffer from sever obesity, and catamenial epilepsy (features seizure exacerbation in relation to the menstrual cycle) is resistant to treatment by standard antiepileptic medications, but may be hormonally controlled. These issues and more are covered, and there is simply no other current single-volume reference with such comprehensive coverage and depth.

Authors selected are the internationally renowned experts for the particular topics on which they write, and the volume is richly illustrated with over 150 figures (50 in color). A collection of articles reviewing our fundamental knowledge of neuroendocrinology, the book provides an essential, affordable reference for researchers, clinicians and graduate students in the area.

- Offering outstanding scholarship, each chapter is written by an expert in the topic area and approximately 25% of chapters are written by international contributors (7 countries represented)
- Provides more fully vetted expert knowledge than any existing work with broad appeal for the US, UK and Europe, accurately crediting the contributions to research in those regions
- Heavily illustrated with 150 figures, approximately 50 in color, presenting the material in the most visually useful form for the reader
- Fully explores various clinical conditions associated with the hormones and the brain (PTSD, TBI, Stress & Anxiety, eating disorders, diabetes, addictive disorders, Alzheimer's, affective disorders)
- Broad coverage of disorders makes the volume relevant to clinicians as well as researchers and basic scientists
A single volume of 41 articles, Hormone/Behavior Relations of Clinical Importance is an authoritative selection of relevant chapters from the Hormones Brain and Behavior 2e MRW, the most comprehensive source of neuroendocrinological information assembled to date (AP July 2009). The study of hormones as they impact the brain and, subsequently, behavior is a central topic in neuroscience, endocrinology and psychiatry. This volume offers an overview of neuroendocrinological topics, approaching the subject from the perspective of hormone-brain function, hormone-behavior relations, sex differences, and the impact on various diseases/pathologies. Many basic human behavioral functions are subject to the influence of hormones - sexual orientation, the experience of pain, fertility, immunity - as are clinical conditions such as diabetes, substance abuse disorder, eating disorders, PTSD, TBI, pain, Alzheimer's, stress/anxiety, affective disorders, and more. There is considerable commercial clinical potential in the study of hormones - drug companies are currently developing a Cholecystokinin (hormonal peptide) booster to reduce appetite in those who suffer from sever obesity, and catamenial epilepsy (features seizure exacerbation in relation to the menstrual cycle) is resistant to treatment by standard antiepileptic medications, but may be hormonally controlled. These issues and more are covered, and there is simply no other current single-volume reference with such comprehensive coverage and depth.Authors selected are the internationally renowned experts for the particular topics on which they write, and the volume is richly illustrated with over 150 figures (50 in color). A collection of articles reviewing our fundamental knowledge of neuroendocrinology, the book provides an essential, affordable reference for researchers, clinicians and graduate students in the area. Offering outstanding scholarship, each chapter is written by an expert in the topic area and approximately 25% of chapters are written by international contributors (7 countries represented) Provides more fully vetted expert knowledge than any existing work with broad appeal for the US, UK and Europe, accurately crediting the contributions to research in those regions Heavily illustrated with 150 figures, approximately 50 in color, presenting the material in the most visually useful form for the reader Fully explores various clinical conditions associated with the hormones and the brain (PTSD, TBI, Stress & Anxiety, eating disorders, diabetes, addictive disorders, Alzheimer's, affective disorders) Broad coverage of disorders makes the volume relevant to clinicians as well as researchers and basic scientists

Contributors


R.A. Allison     (29, Transsexualism), CIGNA Medical Group of Arizona, Phoenix, AZ, USA

L. Baor     (28, Assisted Reproduction in Infertile Women), Tel-Aviv, Israel

S.L. Berga     (22, Premenstrual Dysphoric Disorder), Emory University, Atlanta, GA, USA

K.J. Berkley     (36, Pain: Sex/Gender Differences), Florida State University, Tallahassee, FL, USA

M. Bettendorf     (30, Disorders of Salt and Fluid Balance), University Clinic of Heidelberg, Heidelberg, Germany

S. Bocklandt     (10, The Biology of Sexual Orientation and Gender Identity), UCLA School of Medicine, Los Angeles, CA, USA

L. Borg     (35, Short-Acting Opiates vs. Long-Acting Opioids), The Rockefeller University, New York, NY, USA

G.D. Braunstein     (19, Diseases of Hypothalamic Origin), Cedars-Sinai Medical Center, Los Angeles, CA, USA

R.S. Bridges     (13, Prolactin Actions in the Brain), Tufts University School of Veterinary Medicine, North Grafton, MA, USA

W. Byne     (11, Sexual Orientation in Men and Women), Mount Sinai School of Medicine, New York, NY, USA

L. Cahill     (6, Sex Differences in Human Brain Structure and Function), University of California, Irvine, CA, USA

J.D. Carmichael     (19, Diseases of Hypothalamic Origin), Cedars-Sinai Medical Center, Los Angeles, CA, USA

B.J. Carroll     (21, Mood Disorders), Pacific Behavioral Research Foundation, Carmel, CA, USA

M.B.C.M. Cools     (26, Genetic Defects of Female Sexual Differentiation), Ghent University, Ghent, Belgium

T.J. Creel     (7, Sex Differences in CNS Neurotransmitter Influences on Behavior), Saint Vincent College, Latrobe, PA, USA

L. Czibere     (1, Genetic Transmission of Behavior and Its Neuroendocrine Correlates), Max Planck Institute of Psychiatry, Munich, Germany

M. Daly     (12, Sex Differences in Competitive Confrontation and Risk-taking), McMaster University, Hamilton, ON, Canada

A.B. Dessens     (26, Genetic Defects of Female Sexual Differentiation), Sophia Children’s Hospital/Erasmus MC, Rotterdam, The Netherlands

S.L.S. Drop     (26, Genetic Defects of Female Sexual Differentiation), Sophia Childen’s Hospital/Erasmus MC, Rotterdam, The Netherlands

N.N. Ekhator     (16, Brain Peptides: From Laboratory to Clinic), University of Cincinnati, Cincinnati, OH, USA

J. Emens     (17, Melatonin Actions in the Brain), Oregon Health and Science University, Portland, OR, USA

A.J. Fiocco     (25, Aging and Alzheimer’s Disease), University of California, San Francisco, CA, USA

C.A. Frye     (15, Neurosteroids: From Basic Research to Clinical Perspectives), University at Albany-State University of New York, Albany, NY, USA

S.N. Garfinkel     (20, Stress and Anxiety Disorders), University of Michigan School of Medicine, Ann Arbor, MI, USA

N.E. Gentile     (2, Hypothalamic-Pituitary-Adrenal Cortical Axis), Saint Vincent College, Latrobe, PA, USA

T.D. Geracioti, Jr.     (16, Brain Peptides: From Laboratory to Clinic), University of Cincinnati, Cincinnati, OH, USA

E.S. Ginsburg     (32, Alcohol Abuse: Endocrine Concomitants), Brigham and Women’s Hospital, Boston, MA, USA

M.B. Goetz     (38, Human Immunodeficiency Virus and AIDS), VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA

L.J. Gooren     (11, Sexual Orientation in Men and Women), VU University Medical Center, Amsterdam, The Netherlands

D.R. Grattan     (13, Prolactin Actions in the Brain), University of Otago, Dunedin, New Zealand

J.A. Grootegoed     (26, Genetic Defects of Female Sexual Differentiation), Erasmus MC, Rotterdam, The Netherlands

B. Hambsch     (1, Genetic Transmission of Behavior and Its Neuroendocrine Correlates), Max Planck Institute of Psychiatry, Munich, Germany

V.L. Harsh     (4, Hypothalamic-Pituitary-Gonadal Axis in Women), National Institutes of Health, Bethesda, MD, USA

M. Hines     (8, Gonadal Hormones and Sexual Differentiation of Human Brain and Behavior), University of Cambridge, Cambridge, UK

A. Holdcroft     (36, Pain: Sex/Gender Differences), Imperial College London, London, UK

J. Imperato-McGinley     (27, Genetic Defects of Male Sexual Differentiation), Weill Medical College of Cornell University, New York, NY, USA

R.T. Joffe     (3, Hypothalamic-Pituitary-Thyroid Axis), New Jersey Medical School, Maplewood, NJ, USA

B.A. Kaminski     (9, Human Puberty: Physiology and Genetic Regulation), Rainbow Babies and Children’s Hospital, Cleveland, OH, USA

J. Kaskow     (16, Brain Peptides: From Laboratory to Clinic), University of Pittsburgh Medical Center, Pittsburgh, PA, USA

I. Kravets     (35, Short-Acting Opiates vs. Long-Acting Opioids), The Rockefeller University, New York, NY, USA

M.J. Kreek     (35, Short-Acting Opiates vs. Long-Acting Opioids), The Rockefeller University, New York, NY, USA

R. Landgraf     (1, Genetic Transmission of Behavior and Its Neuroendocrine Correlates), Max Planck Institute of Psychiatry, Munich, Germany

Z. Laron     (14, Growth Hormone and Insulin-Like Growth Factor-1: Effects on the Brain), Tel Aviv University, Tel Aviv, Israel

T. Lenhard     (30, Disorders of Salt and Fluid Balance), University Clinic of Heidelberg, Heidelberg, Germany

A.J. Lewy     (17, Melatonin Actions in the Brain), Oregon Health and Science University, Portland, OR, USA

I. Liberzon     (20, Stress and Anxiety Disorders), University of Michigan School of Medicine, Ann Arbor, MI, USA

J. Licinio     (24, Anorexia Nervosa and Bulimia Nervosa), University of Miami Miller School of Medicine, Miami, FL, USA

L.H.J. Looijenga     (26, Genetic Defects of Female Sexual Differentiation), Erasmus MC, Rotterdam, The Netherlands

C. Lord     (25, Aging and Alzheimer’s Disease), McMaster University Women’s Health Concerns Clinic, Hamilton, ON, Canada

S.J. Lupien     (25, Aging and Alzheimer’s Disease), Université de Montréal, Montreal, QC, Canada

L.F. Martinez     (22, Premenstrual Dysphoric Disorder), University of California, San Diego, La Jolla, CA, USA

B.E. Masel     (37, Traumatic Brain Injury), Transitional Learning Center at Galveston, Galveston, TX, USA

J.M. McKlveen     (2, Hypothalamic-Pituitary-Adrenal Cortical Axis), Saint Vincent College, Latrobe, PA, USA

N.K. Mello     (32, Alcohol Abuse: Endocrine Concomitants; 34, Cocaine, Hormones and Behavior), McLean Hospital and Harvard Medical School, Boston, MA, USA

S. Meltzer-Brody     (4, Hypothalamic-Pituitary-Gonadal Axis in Women), University of North Carolina at Chapel Hill, Chapel Hill, NC,...

PDFPDF (Adobe DRM)
Größe: 3,6 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: PDF (Portable Document Format)
Mit einem festen Seiten­layout eignet sich die PDF besonders für Fach­bücher mit Spalten, Tabellen und Abbild­ungen. Eine PDF kann auf fast allen Geräten ange­zeigt werden, ist aber für kleine Displays (Smart­phone, eReader) nur einge­schränkt geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

EPUBEPUB (Adobe DRM)
Größe: 11,6 MB

Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM

Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belle­tristik und Sach­büchern. Der Fließ­text wird dynamisch an die Display- und Schrift­größe ange­passt. Auch für mobile Lese­geräte ist EPUB daher gut geeignet.

Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine Adobe-ID und die Software Adobe Digital Editions (kostenlos). Von der Benutzung der OverDrive Media Console raten wir Ihnen ab. Erfahrungsgemäß treten hier gehäuft Probleme mit dem Adobe DRM auf.
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine Adobe-ID sowie eine kostenlose App.
Geräteliste und zusätzliche Hinweise

Zusätzliches Feature: Online Lesen
Dieses eBook können Sie zusätzlich zum Download auch online im Webbrowser lesen.

Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.

Mehr entdecken
aus dem Bereich
Das Wichtigste für Ärztinnen und Ärzte aller Fachrichtungen

von Ulrich Alfons Müller; Günther Egidi …

eBook Download (2021)
Urban & Fischer Verlag - Fachbücher
36,99